These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 2533616)

  • 21. Nafarelin acetate: a gonadotropin-releasing hormone agonist for the treatment of endometriosis.
    Letassy NA; Thompson DF; Britton ML; Suda RR
    DICP; 1990 Dec; 24(12):1204-9. PubMed ID: 2151003
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New therapy for endometriosis.
    Barbieri RL
    N Engl J Med; 1988 Feb; 318(8):512-4. PubMed ID: 2963214
    [No Abstract]   [Full Text] [Related]  

  • 23. Effects of nafarelin versus danazol on lipids and calcium metabolism.
    Bergquist C
    Am J Obstet Gynecol; 1990 Feb; 162(2):589-91. PubMed ID: 2137977
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiendometrial antibodies in endometriosis measured by an enzyme-linked immunosorbent assay before and after treatment with danazol and nafarelin.
    Moncayo R; Wilken J; Wilde N; Kann D; Leidenberger F
    Obstet Gynecol; 1991 Jan; 77(1):169-70. PubMed ID: 1824574
    [No Abstract]   [Full Text] [Related]  

  • 25. Quantification of endometriosis-associated pain and quality of life during the stimulatory phase of gonadotropin-releasing hormone agonist therapy: a double-blind, randomized, placebo-controlled trial.
    Miller JD
    Am J Obstet Gynecol; 2000 Jun; 182(6):1483-8. PubMed ID: 10871469
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of six months of GnRH agonist therapy for endometriosis. Is there an age-related effect on bone mineral density?
    Agarwal SK
    J Reprod Med; 2002 Jul; 47(7):530-4. PubMed ID: 12170527
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of nafarelin and danazol on vertebral trabecular bone mass in patients with endometriosis.
    Whitehouse RW; Adams JE; Bancroft K; Vaughan-Williams CA; Elstein M
    Clin Endocrinol (Oxf); 1990 Sep; 33(3):365-73. PubMed ID: 2147597
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nafarelin vs. leuprolide acetate depot for endometriosis. Changes in bone mineral density and vasomotor symptoms. Nafarelin Study Group.
    Agarwal SK; Hamrang C; Henzl MR; Judd HL
    J Reprod Med; 1997 Jul; 42(7):413-23. PubMed ID: 9252932
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nafarelin for endometriosis.
    Sharts-Engel NC
    MCN Am J Matern Child Nurs; 1992; 17(4):224. PubMed ID: 1386133
    [No Abstract]   [Full Text] [Related]  

  • 30. Gonadotropin-releasing hormone analogs in the treatment of endometriomas.
    Schenken RS
    Am J Obstet Gynecol; 1990 Feb; 162(2):579-81. PubMed ID: 2137974
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nafarelin in the treatment of infertility caused by endometriosis.
    Barlow DH
    Am J Obstet Gynecol; 1990 Feb; 162(2):576-9. PubMed ID: 2137973
    [TBL] [Abstract][Full Text] [Related]  

  • 32. GnRH analogs: options for endometriosis-associated pain treatment.
    Batzer FR
    J Minim Invasive Gynecol; 2006; 13(6):539-45. PubMed ID: 17097577
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rationale in use of LHRH analogues in endometriosis.
    Shaw RW
    Horm Res; 1989; 32 Suppl 1():110-4. PubMed ID: 2533143
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Indications of GnRH analogues before and after surgery for endometriosis].
    Daraï E; Dubernard G; Azoulay C; Barranger E; Antoine JM; Uzan S
    Gynecol Obstet Fertil; 2005 Dec; 33(12):1014-7. PubMed ID: 16311060
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is it possible to prevent bone loss in young women treated with luteinizing hormone-releasing hormone agonists?
    Riis BJ; Christiansen C; Johansen JS; Jacobson J
    J Clin Endocrinol Metab; 1990 Apr; 70(4):920-4. PubMed ID: 2138631
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative effects of GnRH agonist therapy. Review of clinical studies and their implications.
    Agarwal SK
    J Reprod Med; 1998 Mar; 43(3 Suppl):293-8. PubMed ID: 9564664
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence of similar increases in bone turnover during nafarelin and danazol use in women with endometriosis.
    Ylikorkala O; Nilsson CG; Hirvonen E; Viinikka L
    Gynecol Endocrinol; 1990 Dec; 4(4):251-60. PubMed ID: 2150580
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of uterine leiomyomas and hirsutism with nafarelin.
    Monroe SE; Andreyko J
    J Reprod Med; 1989 Dec; 34(12 Suppl):1029-33. PubMed ID: 2533618
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Prevention and therapy of side effects of gonadotropin-releasing hormone agonist in patients with endometriosis].
    Fang F; Huang M
    Zhonghua Fu Chan Ke Za Zhi; 1999 Aug; 34(8):506-8. PubMed ID: 11360603
    [No Abstract]   [Full Text] [Related]  

  • 40. Combined treatment of endometriosis. GnRH agonists and laparoscopic surgery.
    Hemmings R
    J Reprod Med; 1998 Mar; 43(3 Suppl):316-20. PubMed ID: 9564667
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.